In preclinical studies, our laboratory has shown that ATf, the iron-free form of transferrin (Tf), is a potent neuroprotective agent in ischemic stroke because it reduces the saturation of blood transferrin with iron (TSAT) and inhibits the entry of iron-Tf into the neurons [3]. Here, TF is linked to ischemic stroke.